Top Story

Single dose of bimatoprost ocular insert demonstrates IOP reduction in glaucoma, ocular hypertension

Single dose of bimatoprost ocular insert demonstrates IOP reduction in glaucoma, ocular hypertension
November 25, 2015

LAS VEGAS — A single dose of a novel topical bimatoprost ocular insert demonstrated sustained IOP reduction in patients with glaucoma and ocular hypertension at 6 months, according to phase 2 study results presented here.

“Despite highly effective topical treatments, half of our patients stop using their drops by 1 year, and among those who do continue to use their drops, many of them have difficulty using them properly. ... There is a pressing need for sustained patient behavior independent delivery of glaucoma medications to prevent blindness,” James D. Brandt, MD, said at the American Academy of Ophthalmology annual meeting.


VIDEO: Grover on evidence-based care in patients with diabetes

November 25, 2015
Lori L. Grover, OD, PhD, dean of the Pennsylvania College of Optometry at Salus University, discusses how the use of systemic medications in patients with diabetes…
In the Journals

Peripheral thermometers not clinically accurate

November 25, 2015
In circumstances where body temperature will impact clinical choices, clinicians should use central thermometers, according to a review published in the Annals of

One-third of US diabetes patients do not receive dilated eye exams

November 25, 2015
A survey from Regeneron Pharmaceuticals found that less than half of adults in the U.S. with diabetes recognize their risk for vision loss, according to a company press…
Business News

Spark Therapeutics reports $16.9 million net loss in third quarter

November 25, 2015
Spark Therapeutics reported a net loss of $16.9 million, or $0.70 per basic and diluted share, in the third quarter compared with a net loss of $6.8 million, or $1.22…
More News Headlines »
Meeting News Coverage

Improvements in visual acuity with corneal inlay remain stable long-term

November 16, 2015
NEW ORLEANS – A study involving 253 subjects who received the Kamra corneal inlay in their nondominant eye showed…
More »

Arizona allows sale of adjustable focus eye wear without prescription

October 29, 2015
Arizona now permits the sale of adjustable eye wear without a prescription, based on a ruling by the assistant attorney…
More »

Allergan seeks approval for preservative-free Restasis

November 13, 2015
Allergan announced it has submitted a Prior Approval Supplement for Restasis 0.05% to obtain marketing clearance for a…
More »
Current Issues
View the Current Issue
Primary Care Optometry News